Paperpal Prime Logo

Cellular oncology (Dordrecht) : Impact Factor & More

eISSN: 2211-3436pISSN: 2211-3428

Key Metrics

CiteScore
9.7
SNIP
1.27
Recommended pre-submission checks
Powered by Paperpal by Editage

Cellular oncology (Dordrecht) Journal Specifications

Overview
Publisher SPRINGER
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1989
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Cellular oncology (Dordrecht) ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Cellular oncology (Dordrecht)

Molecular classification identifies aggressive gastrointestinal stromal tumor subtype targetable by PARP inhibitors.
  • 1 Jul 2026
  • Cellular oncology (Dordrecht, Netherlands)
RRM1 competes with NEDD4 to stabilize USP19 by blocking K387 ubiquitination and suppresses autophagy-mediated chemoresistance in colorectal cancer.
  • 29 Jun 2026
  • Cellular oncology (Dordrecht, Netherlands)
ITGB5 promotes immune escape in hepatocellular carcinoma by regulating PD-L1 through SETDB1/Hippo signaling pathway.
  • 29 Jun 2026
  • Cellular oncology (Dordrecht, Netherlands)
Acinar-ductal metaplasia in pancreatitis and pancreatic ductal adenocarcinoma.
  • 29 Jun 2026
  • Cellular oncology (Dordrecht, Netherlands)
Reverse cardio-oncology: neuroendocrine axis activation and cardiovascular-disease-derived factors synergistically remodel the tumor microenvironment.
  • 28 Jun 2026
  • Cellular oncology (Dordrecht, Netherlands)
Tumor lymph node metastasis chip reveals that the NECTIN3-TIGIT axis promotes melanoma metastasis by enhancing treg cell function and inducing CD8+ T cell exhaustion.
  • 25 Jun 2026
  • Cellular oncology (Dordrecht, Netherlands)
Molecular classification identifies aggressive gastrointestinal stromal tumor subtype targetable by PARP inhibitors.
  • 1 Jul 2026
  • Cellular oncology (Dordrecht, Netherlands)
RRM1 competes with NEDD4 to stabilize USP19 by blocking K387 ubiquitination and suppresses autophagy-mediated chemoresistance in colorectal cancer.
  • 29 Jun 2026
  • Cellular oncology (Dordrecht, Netherlands)
ITGB5 promotes immune escape in hepatocellular carcinoma by regulating PD-L1 through SETDB1/Hippo signaling pathway.
  • 29 Jun 2026
  • Cellular oncology (Dordrecht, Netherlands)
Acinar-ductal metaplasia in pancreatitis and pancreatic ductal adenocarcinoma.
  • 29 Jun 2026
  • Cellular oncology (Dordrecht, Netherlands)
Reverse cardio-oncology: neuroendocrine axis activation and cardiovascular-disease-derived factors synergistically remodel the tumor microenvironment.
  • 28 Jun 2026
  • Cellular oncology (Dordrecht, Netherlands)
Tumor lymph node metastasis chip reveals that the NECTIN3-TIGIT axis promotes melanoma metastasis by enhancing treg cell function and inducing CD8+ T cell exhaustion.
  • 25 Jun 2026
  • Cellular oncology (Dordrecht, Netherlands)

FAQs on Cellular oncology (Dordrecht)